118159-48-1

Basic information

• Product Name: Methyl 5'-(hydroxymethyl)-7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5-carboxylate
• Synonyms: Methyl 5'-(hydroxymethyl)-7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5-carboxylate;Bicyclol;4, 4′-dimethoxy-2, 3, 2′, 3′-bis(methylenedioxy)-6-hydroxymethyl-6′-methoxy-carbonyl biphenyl
• CAS NO: 118159-48-1
• Molecular Formula: C19H18O9
• Molecular Weight: 390.34082
• Mol File: 118159-48-1.mol

Chemical Properties

• Boiling Point: 608.1±55.0 °C(Predicted)
• Appearance: white to off-white/
• Density: 1.410±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• Solubility: DMSO: >10mg/mL
• PKA: 13.85±0.10(Predicted)
• CAS DataBase Reference: Methyl 5'-(hydroxymethyl)-7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 5'-(hydroxymethyl)-7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5-carboxylate(118159-48-1)
• EPA Substance Registry System: Methyl 5'-(hydroxymethyl)-7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5-carboxylate(118159-48-1)

Safety Data

• Hazard Codes: N
• Statements: 50/53
• Safety Statements: 60-61
• RIDADR: UN 3077 9 / PGIII
• RTECS: DT4312000
• Hazardous Substances Data: 118159-48-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 5'-(hydroxymethyl)-7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5-carboxylate is used as an active pharmaceutical ingredient for its potential therapeutic effects. The compound's unique structure allows it to interact with specific biological targets, making it a promising candidate for the development of new drugs.
Used in Chemical Synthesis:
In the field of chemical synthesis, Methyl 5'-(hydroxymethyl)-7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5-carboxylate serves as a key intermediate or building block for the synthesis of more complex molecules. Its versatile structure enables it to be used in the creation of a wide range of compounds with various applications.
Used in Material Science:
Methyl 5'-(hydroxymethyl)-7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5-carboxylate is used as a component in the development of advanced materials. Its unique chemical properties can contribute to the creation of materials with specific characteristics, such as improved stability, enhanced reactivity, or tailored physical properties.
Used in Research and Development:
Methyl 5'-(hydroxymethyl)-7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5-carboxylate is also utilized in research and development settings, where it can be employed to study various biological processes, test new synthetic methods, or explore potential applications in different fields. Its unique structure and properties make it an interesting subject for scientific investigation.

Upstream product

• 205117-47-1 7,7'-dimethoxy-5'-(methoxycarbonyl)-4,4'-bibenzo[d][1,3]dioxole-5-carboxylic acid 
• 1372720-30-3 methyl 5'-(1H-imidazole-1-carbonyl)-7,7'-dimethoxy-(4,4'-bibenzo[d][1,3]dioxole)-5-carboxylate 
• 111897-21-3 dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2,2'-dicarboxylic acid 
• 111897-19-9 DDB 
• 128142-41-6 C₁₈H₁₆O₉ 
• 616-38-6 carbonic acid dimethyl ester 
• 77-78-1 dimethyl sulfate 

Downstream Products

• 1372720-39-2 (E)-methyl 7,7'-dimethoxy-5'-(3-oxo-3-(3,4,5-trimethoxyphenyl)prop-1-en-1-yl)-(4,4'-bibenzo[d][1,3]dioxole)-5-carboxylate 
• 1372720-40-5 (E)-methyl 7,7'-dimethoxy-5'-(3-(4-nitrophenyl)-3-oxoprop-1-en-1-yl)-(4,4'-bibenzo[d][1,3]dioxole)-5-carboxylate 
• 1372720-41-6 (E)-methyl 5'-(2-cyano-3-(4-methoxyphenyl)-3-oxoprop-1-en-1-yl)-7,7'-dimethoxy-(4,4'-bibenzo[d][1,3]dioxole)-5-carboxylate 
• 1372720-42-7 (E)-methyl 5'-(2-cyano-3-oxo-3-(p-tolyl)prop-1-en-1-yl)-7,7'-dimethoxy-(4,4'-bibenzo[d][1,3]dioxole)-5-carboxylate 
• 1372720-43-8 (E)-methyl 5'-(2-cyano-3-oxo-3-(3,4,5-trimethoxyphenyl)prop-1-en-1-yl)-7,7'-dimethoxy-(4,4'-bibenzo[d][1,3]dioxole)-5-carboxylate 
• 1372720-32-5 (E)-methyl 7,7'-dimethoxy-5'-(3-oxo-3-phenylprop-1-en-1-yl)-{4,4'-bibenzo[d][1,3]dioxole}-5-carboxylate 
• 1372720-33-6 (E)-5'-(3-(4-hydroxy)phenyl-3-oxo-1-propenyl)-7,7'-dimethoxy-4,4'-dibenzo[d] [1,3]dioxol-5-carboxylic acid methyl ester 
• 1372720-34-7 (E)-methyl 7,7'-dimethoxy-5'-(3-(4-methoxyphenyl)-3-oxoprop-1-en-1-yl)-(4,4'-bibenzo[d][1,3]dioxole)-5-carboxylate 
• 1372720-35-8 (E)-methyl 7,7'-dimethoxy-5'-(3-(2-methoxyphenyl)-3-oxoprop-1-en-1-yl)-(4,4'-bibenzo[d][1,3]dioxole)-5-carboxylate 
• 1372720-36-9 (E)-methyl 5'-(3-(2,4-dimethoxyphenyl)-3-oxoprop-1-en-1-yl)-7,7'-dimethoxy-{4,4'-bibenzo[d][1,3]dioxole}-5-carboxylate 
• 1372720-37-0 (E)-methyl 5'-(3-(2,5-dimethoxyphenyl)-3-oxoprop-1-en-1-yl)-7,7'-dimethoxy-(4,4'-bibenzo[d][1,3]dioxole)-5-carboxylate 

Relevant articles and documents

Alkoxybiphenyl alpha, beta-unsaturated amide compound and preparing method and medical application thereof

The invention relates to an alkoxybiphenyl alpha, beta-unsaturated amide compound and a preparing method and medical application thereof, and belongs to the fields of medicinal chemistry and pharmacotherapeutics. The invention provides application of the compound shown in the formula I or pharmaceutically acceptable salt thereof in preparing drugs for antioxidation related diseases, especially theapplication in preparing anti-inflammatory drugs or antioxidant drugs. (The formula is shown in the description.).

Alkoxybiphenyl/chalcone hybrid compound and preparing method and medical application thereof

The invention relates to an alkoxybiphenyl/chalcone hybrid compound and a preparing method and medical application thereof, and belongs to the fields of medicinal chemistry and pharmacotherapeutics. The invention provides application of the compound shown in the formula I or pharmaceutically acceptable salt thereof in preparing drugs for antioxidation related diseases, especially the application in preparing anti-inflammatory drugs or antioxidant drugs. (The formula is shown in the description.).

Method for preparing bicyclol by using bifendate

The invention discloses a method for preparing bicyclol by using bifendate, and belongs to the technical field of the chemical synthesis. The method comprises the following steps: using the bifendate as an initial raw material, hydrolyzing by using strong base, acidizing to obtain biphenyl dioic acid, dehydrating the biphenyl dioic acid to obtain biphenyl anhydride, reducing the biphenyl anhydride to obtain biphenyl alcohol acid, and finally esterifying to obtain the bicyclol. A product synthesized by the method is white solid, and the melting point of the white solid is 138-140 DEG C. The white solid can be determined as the pure bicyclol through a liquid chromatography-mass spectrometry and a nuclear magnetic resonance spectrometry. The method has the characteristics of cheap cost, short synthetic route, high yield, moderate reaction condition, simple post-treatment, and larger industrialized potential.

Novel method for preparing bicyclol with bifendate by one step

The invention discloses a novel preparation method of a compound bicyclol shown as a structural formula (I) as shown in the description. The method comprises the step of performing a one-step reduction reaction in the presence of a reducer by taking bifendate (II) as a starting raw material to obtain bicyclol (I). The method is short in reaction step, easy and simple to operate, high in yield, low in cost, significant in advantage and environment-friendly, is suitable for industrial production, and has a good application prospect.

Bicyclol preparation method and intermediate compound thereof

The invention relates to a bicyclol preparation method and an intermediate compound thereof. Concretely speaking, the invention relates to the preparation method of bicyclol which is 4,4'-dimethoxy-5,6,5',6'-bis(methy-lenedioxy)-2-hydroxymethyl-2'-methoxycarbonyl-biphenyl shown in a formula (1), and the intermediate compound thereof.

Synthesis and evaluation of substituted dibenzo[c,e]azepine-5-ones as P-glycoprotein-mediated multidrug resistance reversal agents

A series of substituted dibenzo[c,e]azepine-5-ones (7a-h) were synthesized and evaluated as P-glycoprotein (P-gp)-mediated multidrug resistance (MDR) reversal agents. The most potent compound 7h could significantly and selectively enhance the chemo-sensit

Synthesis and biological evaluation of bifendate-chalcone hybrids as a new class of potential P-glycoprotein inhibitors

Overexpression of P-glycoprotein (P-gp) is one of the major problems to successful cancer chemotherapy. To find novel effective P-gp inhibitors, a series of bifendate-chalcone hybrids were synthesized and evaluated. Among them, the most active compound 8g

Bis (methylenedioxy) biphenyl compounds useful for the treatment of liver diseases

Bis(methylenedioxy)biphenyl compounds represented by the formula STR1 wherein R is an alkyl group having 1 to 6 carbon atoms or a phenyl group, and R' is a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, are disclosed. These compounds are useful as therapeutic agents for liver diseases.